Wellness and performance
Sexual & reproductive
Gonadorelin
Also called GnRH
Gonadorelin is a synthetic GnRH used as a testosterone therapy add-on. See how it works, how limited the evidence is, and where its FDA status stands.
- Reviewed by
- William Maish, MD MBA MPH, Clinical Product Lead
- Published
- October 5, 2026
- Last updated
- October 5, 2026
Key takeaway
Gonadorelin is a synthetic form of the natural reproductive hormone GnRH, used in wellness and men's-health settings as an add-on to testosterone therapy to help preserve fertility and testicular size. The strongest human data come from a different setting. In a 2021 meta-analysis1 of 420 men with congenital hypogonadotropic hypogonadism across seven studies, pulsatile GnRH began sperm production 5.3 months earlier than gonadotropin therapy (p = 0.004), with no significant difference in sperm concentration (p = 0.37) or pregnancy rate (p = 0.11). Direct evidence for the testosterone add-on use is limited, and there is no FDA-approved gonadorelin product for it.
At a glance
| FDA status | Synthetic native GnRH; no current FDA-approved product for the TRT-adjunct use |
| How it works | Stimulates the pituitary to release the reproductive hormones LH and FSH |
| Research | Hormone mechanism is well established, but direct evidence for the TRT-adjunct use is limited |
| Availability | Supplied through compounding pharmacies |
| Evidence strength | Low research |
What is gonadorelin?
Gonadorelin is a synthetic version of gonadotropin-releasing hormone (GnRH), the natural ten-amino acid hypothalamic hormone that controls the reproductive axis. Historically it had limited approvals for diagnostic testing and fertility induction, but those branded products have been discontinued. In wellness and men's-health settings it is used as an add-on to testosterone replacement therapy to help maintain fertility and testicular size, supplied through compounding. There is no current FDA-approved gonadorelin product for that use.
How does it work?
Given in pulses, GnRH stimulates the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which drive the testes to produce testosterone and sperm. This pulsatile mechanism is textbook physiology. A key nuance is that continuous, non-pulsatile exposure instead shuts the system down, so the fertility-preserving rationale depends on intermittent delivery and gonadorelin's very short duration of action. This describes the mechanism, separate from how well the specific add-on use is supported.
Is it FDA-approved?
Not for this use. Gonadorelin's earlier approvals were for diagnostic and fertility-induction purposes, and those products have been discontinued; there is no current FDA-approved gonadorelin product for the testosterone-therapy add-on use, which is supplied through compounding. That places it in the same unsettled peptide-compounding environment as other non-approved peptides, with 2026 FDA advisory activity that is non-binding and no finalized rule.
What does the research show?
The hormone mechanism is well established, but the specific use is thinly supported. Pulsatile GnRH has a recognized role2 in treating certain fertility and hormone-deficiency conditions. However, there is limited direct published human evidence for the specific "add-on to testosterone therapy to preserve fertility and testicular size" use; this application is largely practice-based and extrapolated rather than supported by dedicated controlled trials, and gonadorelin's short duration makes its effect delivery-dependent.
The best human data come from congenital hypogonadotropic hypogonadism, in which GnRH secretion or action fails from birth. A 2021 meta-analysis1 of 420 men across seven studies compared pulsatile GnRH with gonadotropin therapy:
| Outcome | Pulsatile GnRH vs gonadotropin therapy | p value |
| Start of sperm production | 5.3 months earlier | 0.004 |
| Sperm concentration | No significant difference | 0.37 |
| Pregnancy rates | No significant difference | 0.11 |
None of these men were on testosterone therapy, so the results do not show whether gonadorelin works as an add-on.
More for sexual & reproductive
Sources: the physiology of GnRH stimulating LH and FSH is established in the endocrinology literature indexed on PubMed; and FDA records reflecting the discontinued gonadorelin products. This document is educational, is not medical advice or a health claim, and is not an offer to sell any product.